Association of Biologic Therapy With Coronary Inflammation in Patients With Psoriasis as Assessed by Perivascular Fat Attenuation Index

医学 四分位间距 银屑病 内科学 弗雷明翰风险评分 银屑病面积及严重程度指数 冠状动脉疾病 前瞻性队列研究 生物标志物 心脏病学 疾病 皮肤病科 生物化学 化学
作者
Youssef A. Elnabawi,Evangelos K. Oikonomou,Amit Kumar Dey,Jennifer Mâncio,Justin A. Rodante,Milena Aksentijevich,Harry Choi,Andrew Keel,Julie A. Erb-Alvarez,Heather Teague,Aditya A. Joshi,Martin Peter Playford,Benjamin Lockshin,Andrew D. Choi,Joel M. Gelfand,Marcus Y. Chen,David A. Bluemke,Cheerag C. Shirodaria,Charalambos A. Antoniades,Nehal N. Mehta
出处
期刊:JAMA Cardiology [American Medical Association]
卷期号:4 (9): 885-885 被引量:252
标识
DOI:10.1001/jamacardio.2019.2589
摘要

Importance: Psoriasis is a chronic inflammatory skin disease associated with increased coronary plaque burden and cardiovascular events. Biologic therapy for psoriasis has been found to be favorably associated with luminal coronary plaque, but it is unclear whether these associations are attributable to direct anti-inflammatory effects on the coronary arteries. Objective: To investigate the association of biologic therapy with coronary inflammation in patients with psoriasis using the perivascular fat attenuation index (FAI), a novel imaging biomarker that assesses coronary inflammation by mapping spatial changes of perivascular fat composition via coronary computed tomography angiography (CCTA). Design, Setting, and Participants: This prospective cohort study performed from January 1, 2013, through March 31, 2019, analyzed changes in FAI in patients with moderate to severe psoriasis who underwent CCTA at baseline and at 1 year and were not receiving biologic psoriasis therapy at baseline. Exposures: Biologic therapy for psoriasis. Main Outcomes and Measures: Perivascular FAI mapping was performed based on an established method by a reader blinded to patient demographics, visit, and treatment status. Results: Of the 134 patients (mean [SD] age, 51.1 [12.1] years; 84 [62.5%] male), most had low cardiovascular risk by traditional risk scores (median 10-year Framingham Risk Score, 3% [interquartile range, 1%-7%]) and moderate to severe skin disease. Of these patients, 82 received biologic psoriasis therapy (anti-tumor necrosis factor α, anti-interleukin [IL] 12/23, or anti-IL-17) for 1 year, and 52 did not receive any biologic therapy and were given topical or light therapy (control group). At baseline, 46 patients (27 in the treated group and 19 in the untreated group) had a focal coronary atherosclerotic plaque. Biologic therapy was associated with a significant decrease in FAI at 1 year (median FAI -71.22 HU [interquartile range (IQR), -75.85 to -68.11 HU] at baseline vs -76.09 HU [IQR, -80.08 to -70.37 HU] at 1 year; P < .001) concurrent with skin disease improvement (median PASI, 7.7 [IQR, 3.2-12.5] at baseline vs 3.2 [IQR, 1.8-5.7] at 1 year; P < .001), whereas no change in FAI was noted in those not receiving biologic therapy (median FAI, -71.98 [IQR, -77.36 to -65.64] at baseline vs -72.66 [IQR, -78.21 to -67.44] at 1 year; P = .39). The associations with FAI were independent of the presence of coronary plaque and were consistent among patients receiving different biologic agents, including anti-tumor necrosis factor α (median FAI, -71.25 [IQR, -75.86 to -66.89] at baseline vs -75.49 [IQR, -79.12 to -68.58] at 1 year; P < .001) and anti-IL-12/23 or anti-IL-17 therapy (median FAI, -71.18 [IQR, -75.85 to -68.80] at baseline vs -76.92 [IQR, -81.16 to -71.67] at 1 year; P < .001). Conclusions and Relevance: In this study, biologic therapy for moderate to severe psoriasis was associated with reduced coronary inflammation assessed by perivascular FAI. This finding suggests that perivascular FAI measured by CCTA may be used to track response to interventions for coronary artery disease.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
ali完成签到,获得积分10
1秒前
sy完成签到 ,获得积分10
1秒前
2秒前
wuly发布了新的文献求助10
2秒前
2秒前
3秒前
3秒前
小叮当发布了新的文献求助10
3秒前
原儿完成签到,获得积分10
3秒前
大力的纸鹤完成签到,获得积分10
3秒前
3秒前
学术雷锋发布了新的文献求助10
4秒前
菜菜包完成签到,获得积分10
4秒前
呼延忘幽发布了新的文献求助10
5秒前
忐忑的子骞完成签到,获得积分10
5秒前
浮生完成签到,获得积分10
5秒前
6秒前
6秒前
天地一沙鸥完成签到,获得积分10
6秒前
Aurora发布了新的文献求助20
6秒前
pipizhu完成签到,获得积分10
7秒前
小鱼爱吃肉的应助被愉快翩跹采纳,获得10
7秒前
肆_完成签到 ,获得积分10
7秒前
郑璇完成签到,获得积分10
9秒前
9秒前
9秒前
咯咯哒发布了新的文献求助10
10秒前
共享精神的应助被欣慰的嘉熙采纳,获得10
10秒前
10秒前
传奇3的应助被lyy采纳,获得10
11秒前
fire发布了新的文献求助30
11秒前
Lll发布了新的文献求助10
11秒前
重要惜雪完成签到 ,获得积分10
11秒前
12秒前
呼延忘幽完成签到,获得积分10
13秒前
huanj发布了新的文献求助10
13秒前
Lucas的应助被栾花花采纳,获得10
14秒前
笨笨蜻蜓发布了新的文献求助10
15秒前
学术雷锋发布了新的文献求助10
15秒前
16秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1500
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
John McDowells Bildungstheorie 800
八旗制度の研究 600
Analyses de reconnaissances de dettes passées devant les échevins d'Ypres (1249-1291) 600
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8161319
求助须知:如何正确求助?哪些是违规求助? 9556017
关于积分的说明 21731933
捐赠科研通 7751355
什么是DOI,文献DOI怎么找? 3427537
关于科研通互助平台的介绍 2552583
邀请新用户注册赠送积分活动 2471987